Neuromuscular Funding and Employment Opportunities

MDF 2026 Pilot Grants RFA

Proposals Due: March 20, 2026 , 5PM PT .
The Myotonic Dystrophy Foundation (MDF) is now accepting applications for its 2026 Pilot Grants RFA. This one-year award supports researchers advancing basic, translational, or clinical research in myotonic dystrophy (DM), with a focus on treatment, care, and therapeutic development.

Tier 2 Canada Research Chair on Neuromuscular Disease and Related Cardiac Disorders.

Application Deadline: April 4, 2026.
The University of Ottawa is seeking a clinician scientist for a Tier 2 Canada Research Chair in neuromuscular disease and related cardiac disorders. The role includes clinical work at The Ottawa Hospital, research through the Ottawa Hospital Research Institute, and participation in the Brain Heart Interconnectome program. This Chair is intended for an emerging researcher with strong potential for leadership in this field.

Call for experts to support the IRDiRC Task Force on Digital Twins in Rare Disease Research and Care

Deadline: 20th of February, 2026.
The Therapies Scientific Committee (TSC) is establishing a Task Force on Digital Twins in Rare Disease Research and Care to assess the opportunities and barriers associated with their use, ensuring responsible, equitable, and sustainable implementation. IRDiRC is looking for experienced members to populate this Task Force.

Neuromuscular/EMG Fellowship Program: The Ottawa Hospital – University of Ottawa

Application Deadline on May 31st, 2026 | The Ottawa Hospital NeuroMuscular Centre is accepting applications for 1 or 2 year funded Neuromuscular / Clinical Neurophysiology (EMG) fellowships, to begin in July 2027.

2026 AFM‑Téléthon Funding Programs

Renewal Deadline: 10 March 2026 | Research Grants, Postdoctoral Fellowships.
AFM‑Téléthon has launched its 2026 funding programs, with several opportunities open to international applicants, including Canadian researchers. These calls support innovative work in neuromuscular disease mechanisms, therapeutic development, and training.

Spring 2026 – CIHR Reviewer in Training (RiT) Program

March 4, 2026 Application deadline for the Spring 2026 Project Grant Competition
Apply for CIHR’s Reviewer in Training Program to gain guided or full reviewer experience in the Spring 2026 Project Grant competition.
The Canadian Institutes of Health Research (CIHR) Reviewer in Training (RiT) Program provides Early Career Researchers (ECRs) with hands‑on experience in CIHR’s Project Grant peer‑review process. Participants learn directly from experienced reviewers, gain insight into high‑quality peer review, and strengthen their ability to prepare competitive grant applications.

Stem Cell Network Training Opportunities

March 4 & June 2026 | Save the date for upcoming 2026/2027 Stem Cell Network training opportunities!

CIHR Research Excellence, Diversity, and Independence (REDI) 2025 Early Career Transition Award

Application Deadline: June 16, 2026.
The CIHR Research Excellence, Diversity, and Independence (REDI, pronounced “ready”) Early Career Transition Award supports trainees such as post-doctoral researchers, clinicians, and research associates, from specific underrepresented groups to launch independent their research careers in Canada.
*** This funding opportunity uses new application resources, including the tri-agency CV and REDI 2025 Linkage Tool.
*** CIHR will also host webinars to help applicants and host institutions understand the requirements and answer questions about “REDI 2025”. Registration for the webinars are now open on our Upcoming Events page.

CIHR Catalyst Grant – Digital Health

Registration Deadline: December 16, 2025 | Application Deadline: March 17, 2026.
CIHR-IMHA is now accepting applications for its Catalyst Grant – Digital Health in areas including Patient Engagement, Digital Health, Pain, and Open Science, for Canada-based projects with activities held in Canada or abroad.

Subsidized Clinical Trial Services from RareKids-CAN

Did you know RareKids-CAN offers a range of subsidized services for investigator-initiated (academic-led) pediatric rare disease clinical trials?

See more career opportunities: